Vecuronium Bromide Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-236

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vecuronium Bromide (NDC 55150-236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vecuronium-figure-1 (Vecuronium Fig1)

Vecuronium-figure-1 (Vecuronium Fig1)
This text contains information regarding a medication named Vecuronium Bromide, which is a paralyzing agent that must be reconstituted with sterile water for injection or compatible LV solutions. The medication should be used within 5 days of reconstitution and any unused portion should be discarded within 24 hours. The medication should be protected from light and facilities must be immediately available for artificial respiration as it may cause respiratory arrest. The package insert should be consulted for the usual dosage and storage instructions. The medication contains benzyl alcohol and is not suitable for use in newborns. The text is a warning and notice to healthcare professionals and contains a registered trademark.*
FDA Label Image

Vecuronium-figure-2 (Vecuronium Fig2)

Vecuronium-figure-2 (Vecuronium Fig2)
This is a product information sheet for a medication called Vecuronium Bromide used for injection. It comes in two strengths, 1mg/mL and 10mg/mL, and is sold as a sterile and non-pyrogenic lyophilized powder formulation. The trademark mentioned is "Hovaplu" by Vi, Inc. The sheet includes a warning that it is a paralyzing agent. The manufacturer is Huroodcs Prma U. There is also a warning about the potential danger of using the medication.*
FDA Label Image

Vecuronium-figure-3 (Vecuronium Fig3)

Vecuronium-figure-3 (Vecuronium Fig3)
This is a warning label for Vecuronium Bromide Injection, a paralyzing agent that may cause respiratory arrest. The drug is sterile and lyophilized, and must be reconstituted with bacteriostatic water or sterile water before use. It is not safe for use in newborns due to the presence of benzyl alcohol. The dosage and storage instructions can be found in the package insert. The label also includes the NDC number and a trademark name for the product. Finally, there are fields for recording the date and time of reconstitution, as well as the batch number and expiry date.*
FDA Label Image

Vecuronium-figure-4 (Vecuronium Fig4)

FDA Label Image

Vecuronium-figure-5 (Vecuronium Fig5)

Vecuronium-figure-5 (Vecuronium Fig5)
This is a label for Vecuronium Bromide for Injection, indicating the concentration of the drug (mg/mL) and a code for lot tracking. The label also includes spaces to indicate the date and time the drug was mixed, as well as the lot expiration date.*
FDA Label Image

Vecuronium Bromide Chemcal Structure (Vecuronium Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.